vs

Side-by-side financial comparison of Emerson Electric (EMR) and Royal Caribbean Group (RCL). Click either name above to swap in a different company.

Emerson Electric is the larger business by last-quarter revenue ($4.3B vs $4.3B, roughly 1.0× Royal Caribbean Group). Royal Caribbean Group runs the higher net margin — 17.9% vs 13.9%, a 4.0% gap on every dollar of revenue. On growth, Royal Caribbean Group posted the faster year-over-year revenue change (13.2% vs 4.1%). Over the past eight quarters, Royal Caribbean Group's revenue compounded faster (1.8% CAGR vs -0.3%).

Emerson Electric Co. is an American multinational corporation headquartered in St. Louis, Missouri. The Fortune 500 company delivers a range of engineering services, manufactures industrial automation equipment, climate control systems, and precision measurement instruments, and provides software engineering for industrial, commercial, and consumer markets.

Royal Caribbean Group, formerly known as Royal Caribbean Cruises Ltd., is a cruise holding company headquartered in Miami, Florida, United States and incorporated in Liberia. It is the world's second-largest cruise line operator, after Carnival Corporation & plc. As of September 2025, Royal Caribbean Group fully owns three cruise lines: Royal Caribbean International, Celebrity Cruises, and Silversea Cruises. It also holds a 50% stake in TUI Cruises, which operates Mein Schiff and Hapag-Lloyd ...

EMR vs RCL — Head-to-Head

Bigger by revenue
EMR
EMR
1.0× larger
EMR
$4.3B
$4.3B
RCL
Growing faster (revenue YoY)
RCL
RCL
+9.1% gap
RCL
13.2%
4.1%
EMR
Higher net margin
RCL
RCL
4.0% more per $
RCL
17.9%
13.9%
EMR
Faster 2-yr revenue CAGR
RCL
RCL
Annualised
RCL
1.8%
-0.3%
EMR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
EMR
EMR
RCL
RCL
Revenue
$4.3B
$4.3B
Net Profit
$605.0M
$762.0M
Gross Margin
53.2%
Operating Margin
17.8%
21.9%
Net Margin
13.9%
17.9%
Revenue YoY
4.1%
13.2%
Net Profit YoY
3.4%
36.3%
EPS (diluted)
$1.07
$2.76

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
EMR
EMR
RCL
RCL
Q1 26
$4.3B
Q4 25
$4.3B
$4.3B
Q3 25
$4.9B
$5.1B
Q2 25
$4.6B
$4.5B
Q1 25
$4.4B
$4.0B
Q4 24
$4.2B
$3.8B
Q3 24
$4.6B
$4.9B
Q2 24
$4.4B
$4.1B
Net Profit
EMR
EMR
RCL
RCL
Q1 26
$762.0M
Q4 25
$605.0M
$753.0M
Q3 25
$637.0M
$1.6B
Q2 25
$586.0M
$1.2B
Q1 25
$485.0M
$730.0M
Q4 24
$585.0M
$552.0M
Q3 24
$996.0M
$1.1B
Q2 24
$329.0M
$854.0M
Gross Margin
EMR
EMR
RCL
RCL
Q1 26
Q4 25
53.2%
47.4%
Q3 25
51.9%
51.8%
Q2 25
52.6%
49.7%
Q1 25
53.5%
48.0%
Q4 24
53.5%
45.4%
Q3 24
51.3%
51.1%
Q2 24
52.8%
47.6%
Operating Margin
EMR
EMR
RCL
RCL
Q1 26
21.9%
Q4 25
17.8%
21.9%
Q3 25
16.4%
33.1%
Q2 25
16.1%
29.3%
Q1 25
14.2%
23.6%
Q4 24
18.6%
16.6%
Q3 24
14.7%
33.4%
Q2 24
10.4%
26.7%
Net Margin
EMR
EMR
RCL
RCL
Q1 26
17.9%
Q4 25
13.9%
17.7%
Q3 25
13.1%
30.6%
Q2 25
12.9%
26.7%
Q1 25
10.9%
18.3%
Q4 24
14.0%
14.7%
Q3 24
21.6%
22.7%
Q2 24
7.5%
20.8%
EPS (diluted)
EMR
EMR
RCL
RCL
Q1 26
$2.76
Q4 25
$1.07
$2.76
Q3 25
$1.12
$5.74
Q2 25
$1.04
$4.41
Q1 25
$0.86
$2.70
Q4 24
$1.02
$2.27
Q3 24
$1.74
$4.21
Q2 24
$0.57
$3.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
EMR
EMR
RCL
RCL
Cash + ST InvestmentsLiquidity on hand
$825.0M
Total DebtLower is stronger
$7.6B
$21.3B
Stockholders' EquityBook value
$20.3B
$10.2B
Total Assets
$41.9B
$41.6B
Debt / EquityLower = less leverage
0.37×
2.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
EMR
EMR
RCL
RCL
Q1 26
$825.0M
Q4 25
$825.0M
Q3 25
$432.0M
Q2 25
$735.0M
Q1 25
$386.0M
Q4 24
$388.0M
Q3 24
$418.0M
Q2 24
$391.0M
Total Debt
EMR
EMR
RCL
RCL
Q1 26
$21.3B
Q4 25
$7.6B
$18.2B
Q3 25
$8.9B
$17.2B
Q2 25
$8.3B
$17.6B
Q1 25
$8.2B
$18.0B
Q4 24
$6.6B
$18.5B
Q3 24
$7.7B
$19.0B
Q2 24
$7.1B
$19.8B
Stockholders' Equity
EMR
EMR
RCL
RCL
Q1 26
$10.2B
Q4 25
$20.3B
$10.0B
Q3 25
$20.3B
$10.1B
Q2 25
$19.9B
$9.2B
Q1 25
$19.2B
$8.0B
Q4 24
$20.5B
$7.6B
Q3 24
$21.6B
$7.0B
Q2 24
$20.8B
$6.0B
Total Assets
EMR
EMR
RCL
RCL
Q1 26
$41.6B
Q4 25
$41.9B
$41.6B
Q3 25
$42.0B
$40.1B
Q2 25
$42.5B
$38.5B
Q1 25
$42.0B
$37.5B
Q4 24
$42.6B
$37.1B
Q3 24
$44.2B
$37.1B
Q2 24
$45.6B
$37.0B
Debt / Equity
EMR
EMR
RCL
RCL
Q1 26
2.08×
Q4 25
0.37×
1.81×
Q3 25
0.44×
1.70×
Q2 25
0.42×
1.92×
Q1 25
0.42×
2.26×
Q4 24
0.32×
2.44×
Q3 24
0.36×
2.69×
Q2 24
0.34×
3.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
EMR
EMR
RCL
RCL
Operating Cash FlowLast quarter
$699.0M
$6.5B
Free Cash FlowOCF − Capex
$602.0M
FCF MarginFCF / Revenue
13.9%
Capex IntensityCapex / Revenue
2.2%
Cash ConversionOCF / Net Profit
1.16×
8.48×
TTM Free Cash FlowTrailing 4 quarters
$4.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
EMR
EMR
RCL
RCL
Q1 26
$6.5B
Q4 25
$699.0M
$1.6B
Q3 25
$3.1B
$1.5B
Q2 25
$1.1B
$1.7B
Q1 25
$241.0M
$1.6B
Q4 24
$777.0M
$1.5B
Q3 24
$3.3B
$897.0M
Q2 24
$1.1B
$1.6B
Free Cash Flow
EMR
EMR
RCL
RCL
Q1 26
Q4 25
$602.0M
$116.0M
Q3 25
$2.7B
$-989.0M
Q2 25
$977.0M
$910.0M
Q1 25
$154.0M
$1.2B
Q4 24
$694.0M
$915.0M
Q3 24
$2.9B
$563.0M
Q2 24
$998.0M
$-567.0M
FCF Margin
EMR
EMR
RCL
RCL
Q1 26
Q4 25
13.9%
2.7%
Q3 25
54.9%
-19.2%
Q2 25
21.5%
20.1%
Q1 25
3.5%
30.0%
Q4 24
16.6%
24.3%
Q3 24
63.1%
11.5%
Q2 24
22.8%
-13.8%
Capex Intensity
EMR
EMR
RCL
RCL
Q1 26
Q4 25
2.2%
35.4%
Q3 25
8.9%
47.8%
Q2 25
2.0%
18.4%
Q1 25
2.0%
10.7%
Q4 24
2.0%
14.7%
Q3 24
9.1%
6.8%
Q2 24
2.1%
52.1%
Cash Conversion
EMR
EMR
RCL
RCL
Q1 26
8.48×
Q4 25
1.16×
2.16×
Q3 25
4.86×
0.93×
Q2 25
1.83×
1.44×
Q1 25
0.50×
2.23×
Q4 24
1.33×
2.66×
Q3 24
3.35×
0.81×
Q2 24
3.31×
1.84×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

EMR
EMR

Other$1.8B41%
Software And Systems$1.0B24%
Intelligent Devices$996.0M23%
Safety And Productivity$503.0M12%

RCL
RCL

Segment breakdown not available.

Related Comparisons